Medical policy: H-Wave Electrical Stimulation

Número de política: MP 6.049

Fecha de entrada en vigor: 4/1/2026

Política

The use of H-wave stimulation is considered investigational for all indications, including but not limited to:

• Treatment of pain
• Wound healing
• Post-operative treatment to improve function and/or range of motion

No hay pruebas suficientes para apoyar una conclusión general con respecto a los resultados o beneficios para la salud asociados con este procedimiento.

Referencias cruzadas

• MP 6.020 Transcutaneous Electrical Nerve Stimulation and Transcutaneous Afferent Patterned Stimulation
• MP 6.046 Threshold Electrical Stimulation as a Treatment of Motor Disorders
• MP 6.047 Interferential Current Stimulation
• MP 6.050 Percutaneous Electrical Nerve Stimulation (PENS) and Percutaneous Neuromodulation Therapy (PNT)

Variaciones del producto

Esta política solo se aplica a ciertos programas y productos administrados por Capital Blue Cross y está sujeta a variaciones en los beneficios. Consulte la información adicional a continuación.

FEP PPO - Consulte el Manual de Políticas Médicas de FEP.

Note* - The Federal Employee Program (FEP) Service Benefit Plan does not have a medical policy related to these services.

Descripción/antecedentes

H-wave stimulation is a form of electrical stimulation that differs from other forms of electrical stimulation, such as transcutaneous electrical nerve stimulation (TENS), in terms of its waveform. H-wave stimulation has been used for the treatment of pain related to a variety of etiologies, such as diabetic neuropathy, muscle sprains, temporomandibular joint dysfunctions, or reflex sympathetic dystrophy. H-wave stimulation has also been used to accelerate healing of wounds such as diabetic ulcers and to improve range of motion and function after orthopedic surgery. H-wave electrical stimulation must be distinguished from the H-waves that are a component of electromyography.

Fundamento

Resumen

Two small controlled trials are insufficient to permit conclusions about the effectiveness of H-wave electrical stimulation as a pain treatment. Additional sham-controlled studies are needed from other investigators, preferably studies that are clearly blinded, specify the handling of any withdrawals, and provide long-term comparative follow-up data. One small randomized controlled trial (RCT) represents insufficient evidence on the effectiveness of H-wave stimulation for improving strength and function after rotator cuff surgery. No comparative studies have been published evaluating H-wave stimulation to accelerate wound healing. In addition, no studies were identified that evaluated H-wave stimulation for any clinical application other than those described above.

Recent literature suggests that H-wave electrical stimulation may provide clinically meaningful pain reduction and could serve as an adjunct within non-opioid, multimodal pain management strategies (Williamson et al.). This consideration is particularly relevant in the context of the ongoing opioid crisis. However, current evidence also emphasizes the need for higher-quality research and rigorous long-term clinical trials to validate appropriate use and define specific indications for most forms of electrical stimulation (Williamson et al.; Allen et al.). The evidence is insufficient to determine that the technology results in an improvement in the net health outcome.

Definiciones

N/D

Exención de responsabilidad

Las políticas médicas de Capital Blue Cross se utilizan para determinar la cobertura de tecnologías, procedimientos, equipos y servicios médicos específicos. Estas políticas médicas no constituyen un consejo médico y están sujetas a cambios según lo permita la ley o la evidencia clínica aplicable de las pautas de tratamiento independientes. Los proveedores que brindan tratamiento son individualmente responsables de los consejos médicos y el tratamiento de los miembros. Estas políticas no son una garantía de cobertura o pago. El pago de las reclamaciones está sujeto a la determinación del programa de beneficios del miembro y la elegibilidad en la fecha del servicio, y a la determinación de que los servicios son médicamente necesarios y apropiados. El procesamiento final de una reclamación se basa en los términos del contrato que se aplican al programa de beneficios del miembro, incluidas las limitaciones y exclusiones de beneficios. Si un proveedor o miembro tiene alguna pregunta sobre esta política médica, debe comunicarse con Servicios para proveedores o Servicios para miembros de Capital Blue Cross.

Información de codificación

Nota: Es posible que esta lista de códigos no sea exhaustiva y que los códigos estén sujetos a cambios en cualquier momento. La identificación de un código en esta sección no denota cobertura, ya que la cobertura está determinada por los términos de la información de beneficios del miembro. Además, no todos los servicios cubiertos son elegibles para un reembolso por separado.

Investigational; therefore, not covered

Referencias

1. Blum K, Chen AL, Chen TJ, et al. The H-Wave device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis. Adv Ther. 2008; 25(7): 644-57. PMID
2. Kumar D, Marshall J. Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation. Diabetes Care. 1997; 20(11): 1702-5. PMID
3. Kumar D, Alvaro MS, Julka IS, et al. Diabetic peripheral neuropathy. Effectiveness of electrotherapy and amitriptyline for symptomatic relief. Diabetes Care. 1998; 21(8): 1322-5. PMID
4. Julka IS, Alvaro M, Kumar D. Beneficial effects of electrical stimulation for neuropathic symptoms in diabetes patients. J Foot Ankle Surg. 1998; 37(3): 191-4. PMID
5. Blum K, DiNubile NA, Tekten T, et al. H-Wave, a nonpharmacological alternative for the treatment of patients with chronic soft tissue inflammation and neuropathic pain: a preliminary statistical outcome study. Adv Ther. 2006; 23(3): 446-55. PMID
6. Blum K, Chen TJ, Martinez-Pons M, et al. The H-Wave small muscle fiber stimulator, a nonpharmacological alternative for the treatment of chronic soft-tissue injury and neuropathic pain: an extended population observational study. Adv Ther. 2006; 23(5): 739-49. PMID
7. Blum K, Chen AL, Chen TJ, et al. Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE device therapy: a case series. Cases J. 2010; 3: 54. PMID
8. Blum K, Chen AL, Chen TJ, et al. Repetitive H-wave device stimulation and programmed electrical increases in the range of motion of post-operative rotator cuff reconstruction in a double-blinded randomized placebo controlled human study. BMC Musculoskelet Disord. 2009; 10: 132. PMID
9. Williamson SK, Rodriguez HC, Gonzaba A, Poddar SN, Norwood SM, Gupta A. H-Wave® Device Stimulation: A Critical Review. J Pers Med. 2021; 11(11): 1134.
10. Bajaj A, Han D, Elman I, et al. Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy-A Case-Series. J Pers Med. 2023; 13(2): 336.
11. Allen CB, Williamson TK, Norwood SM, Gupta A. Do Electrical Stimulation Devices Reduce Pain or Improve Function?-A Comparative Review. Pain Ther. 2023; 12(6): 1339-1354.

Antecedentes de la política